Continuous Bilateral Erector of Spine Plane Block at T8 for Extensive Lumbar Spine Fusion Surgery: Case Report.
Carlos Rodrigues Almeida, Ana Raquel Oliveira, Pedro Cunha
https://pubmed.ncbi.nlm.nih.gov/30758122/Actively Recruiting
Led by Stanford University · Updated on 2025-05-01
50
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying pain management after spinal fusion surgery for idiopathic scoliosis in children and adolescents. The trial evaluates the use of the erector spinae plane block ESPB, a new regional anesthesia technique, to improve pain control and reduce opioid use after surgery. The study also investigates how this approach affects the bodys inflammatory response related to acute pain after major surgery. Participants are randomly assigned to receive either the ESPB before surgery or the standard pain management care, which involves multiple types of pain relief including opioids. The ESPB involves injecting local anesthetic between muscles near the spine to block certain nerves, aiming to provide effective pain relief without affecting motor function. Patients who do not consent to randomization may still participate by allowing data and sample collection related to their perioperative care. During the hospital stay, which averages about five days, researchers will monitor length of stay, opioid use, lidocaine levels in the blood, patient-reported pain scores, and mobility after surgery. This study includes detailed assessments to understand the impact of ESPB on recovery and pain control in pediatric scoliosis surgery patients.
CONDITIONS
Erector Spinae Plane Blockade in Pediatric Scoliosis Surgery Patients
B
Ban Tsui, MD
C
Chynna Villanueva, BS, RN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Stanford University
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | ESPB (Regional Block + Standard Care) | Standard Care (No ESPB) |
|---|---|---|
| What it is | A regional anesthesia procedure where local anesthetic is injected between the erector spinae muscle and the transverse process, designed to block nerve pain signals during and after spine surgery. | Standard perioperative pain management without additional ESPB, which may include systemic pain medications such as opioids, acetaminophen, nonsteroidal anti-inflammatory drugs, and routine local measures. |
| Role in trial | Evaluated as an additional technique for perioperative pain control in pediatric scoliosis surgery, with outcomes including opioid use, pain scores, and safety. | Serves as the standard comparator group to determine the added value of ESPB over usual perioperative pain management. |
| Primary use | Regional pain control for pediatric patients undergoing major spine fusion surgery for scoliosis. Intended to reduce pain and lower the need for opioid medications. | Pain management during and after scoliosis surgery using established systemic medications and practices. |
| How it is given or performed | An anesthesiologist injects local anesthetic in the fascial plane deep to the erector spinae muscle and above the transverse process before surgical incision is made. | Systemic medications (like opioids and acetaminophen) are administered intravenously or orally based on patient need; local measures may include infiltration by the surgical team when appropriate. |
| Evidence status | The safety and effectiveness of ESPB in pediatric scoliosis surgery are still under investigation; published case series and small studies support its potential for perioperative pain control, but robust pediatric evidence is limited. | Standard pain management has extensive supporting evidence showing effectiveness at reducing perioperative pain and allowing patient recovery. However, opioid side effects and variability in pain control are documented concerns. |
| Important risks | Risks with ESPB may include local anesthetic toxicity, nerve injury, bleeding, and infection, though serious complications are rare. Safety evidence in pediatric surgery remains limited to case series and reports. | Opioid-based pain management is associated with nausea, vomiting, constipation, sedation, and risk of serious adverse events such as respiratory depression and potential for longer hospitalization. |
| Important limitations | Robust efficacy and safety data in children are lacking. Most published ESPB literature comes from small series in non-pediatric populations, and technique variations exist. | While standard regimens are effective, they may result in opioid-related side effects and inconsistent pain control. There is a clinical need for additional options to reduce opioid use and enhance pain relief. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Through hospital stay, an average of 5 days
Participants receive an erector spinae plane blockade prior to their pediatric scoliosis surgery or standard care with multi-modal opioid pain management during their hospital stay.
Hospital stay visits for approximately 5 days
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Carlos Rodrigues Almeida, Ana Raquel Oliveira, Pedro Cunha
https://pubmed.ncbi.nlm.nih.gov/30758122/Halil Cihan Kose, Selin Guven Kose, David Terence Thomas
https://pubmed.ncbi.nlm.nih.gov/29649625/Jonathan Kline, Ki Jinn Chin
https://pubmed.ncbi.nlm.nih.gov/30392347/Michelle Wheeler, Gary M Oderda, Michael A Ashburn...
https://pubmed.ncbi.nlm.nih.gov/14622770/Benjamin W Sheffer, Derek M Kelly, Leslie N Rhodes...
https://pubmed.ncbi.nlm.nih.gov/28870307/Mauricio Forero, Sanjib D Adhikary, Hector Lopez...
https://pubmed.ncbi.nlm.nih.gov/27501016/Todd L Demmy, Chukwumere Nwogu, Patrick Solan...
https://pubmed.ncbi.nlm.nih.gov/19324125/Josh P Melvin, Rudolph J Schrot, George M Chu...
https://pubmed.ncbi.nlm.nih.gov/29704223/Stanford University
Lead Sponsor